IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    The Docket: NYC Marathon under scrutiny

    20:08
  • Can we expect new felony charges for Couch?

    04:16
  • The Docket: Ethan Couch transfer hearing

    26:17
  • The Docket: SCOTUS union hearing

    23:56
  • The Docket: 1-on-1 with Rice family attorney

    33:02
  • The Docket: NFL concussions debate

    36:18
  • The Docket

    48:48
  • The Docket: 'American Sniper' trial revisited

    52:13
  • In-depth: Captagon, and LGBT Year in Review

    42:12
  • Anonymous hacktivists vs. ISIS

    03:07
  • The Docket: Why digital activism matters

    47:30
  • The Docket: Inside the dangers of K2

    52:24
  • The Docket: How prisoners can start lawsuits

    39:45
  • The Docket: Legalities of Halloween

    45:42
  • The Docket: How winners win

    40:51
  • The Docket: Data privacy

    54:22
  • The Docket’s fall TV season legal line-up

    50:04
  • The Docket: The legality of online mugshots

    50:53
  • The Docket: Is Ohio violating Roe vs. Wade?

    48:12
  • The Docket's ‘Serial’ special: New evidence?

    51:09

In depth: Lucrative business of ISIS drug Captagon

10:59

‘The Guardian’ Middle East Reporter Kareem Shaheen says the cost of making 200,000 Captagon pills is $30,000 dollars and in turn, selling for $600,000 in Saudi Arabia. Vox’s German Lopez says when taken in large quantities, the pill is capable of making Syrian ISIS fighters overcome feelings of fear like beheading individuals while on camera.